Investing

BioAge Labs : BIOA

BIOA

Stock Data

$21.47

$0.70 (3.37%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - SPECIALTY & GENERIC

BioAge Labs, Inc. is a pioneering biotechnology firm based in Montreal, Canada, dedicated to developing therapeutics that enhance healthspan and longevity through advanced research in aging biology. By harnessing innovative insights into the mechanisms of aging, the company focuses on creating targeted treatments for age-related diseases, thereby playing a crucial role in the geriatric healthcare landscape. With a commitment to scientific rigor and collaboration with top-tier research institutions, BioAge is well-positioned to address the significant healthcare challenges posed by aging populations, ultimately striving to improve quality of life and health outcomes globally.

All BioAge Labs Articles

1 Article

Lee Jackson | May 13, 2026 at 7:54 AM EDT

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Akamai Technologies, HEICO, Johnson & Johnson, MasTec, MercadoLibre, Sandisk, Snap, and More

Pre-Market Stock Futures: Futures are trading mixed on Wednesday, after a rough day for technology stocks and the Nasdaq. The…